MidFirst Bank’s Elevance Health ELV Stock Holding History

MidFirst Bank’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.44M	Buy	16,659 +116	+0.7%	+$43K	0.46%	59
2026 Q1	$4.84M	Buy	16,543 +7,579	+85%	+$2.49M	0.4%	64
2025 Q4	$2.95M	Buy	+8,964	New	+$3.03M	0.23%	95

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MidFirst Bank's ELV Position: Q2 2026 in Review

MidFirst Bank increased its Elevance Health (ELV) stake by 0.7% in Q2 2026, buying an estimated $43K and bringing the position to 16,659 shares worth $6.44M. The position accounts for 0.46% of the portfolio, ranked #59.

MidFirst Bank first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,303 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

MidFirst Bank held 16,659 shares of Elevance Health worth $6.44M as of Q2 2026.
MidFirst Bank bought 116 Elevance Health shares in Q2 2026, an estimated $43K.
Elevance Health made up 0.46% of MidFirst Bank's portfolio in Q2 2026, its #59 holding.
MidFirst Bank first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
1,303 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.